OvaScienceSM,
(NASDAQ: OVAS), a life sciences company focused on the discovery,
development and commercialization of new treatments for infertility,
announced today the publication of an in-depth review article by Chief
Scientific Officer, Scott Chappel, Ph.D., regarding the role of
mitochondria ...
read more